Ion mobility spectrometry (IMS) is an interesting complement to mass spectrometry for the characterization of biomolecules, notably because it is sensitive to isomerism. This protocol describes a tandem IMS (IMS/IMS) experiment, which allows the isolation of a molecule and the generation of the mobility profiles of its fragments.
Accurate characterization of chemical structures is important to understand their underlying biological mechanisms and functional properties. Mass spectrometry (MS) is a popular tool but is not always sufficient to completely unveil all structural features. For example, although carbohydrates are biologically relevant, their characterization is complicated by numerous levels of isomerism. Ion mobility spectrometry (IMS) is an interesting complement because it is sensitive to ion conformations and, thus, to isomerism.
Furthermore, recent advances have significantly improved the technique: the last generation of Cyclic IMS instruments offers additional capabilities compared to linear IMS instruments, such as an increased resolving power or the possibility to perform tandem ion mobility (IMS/IMS) experiments. During IMS/IMS, an ion is selected based on its ion mobility, fragmented, and reanalyzed to obtain ion mobility information about its fragments. Recent work showed that the mobility profiles of the fragments contained in such IMS/IMS data can act as a fingerprint of a particular glycan and can be used in a molecular networking strategy to organize glycomics datasets in a structurally relevant way.
The goal of this protocol is thus to describe how to generate IMS/IMS data, from sample preparation to the final Collision Cross Section (CCS) calibration of the ion mobility dimension that yields reproducible spectra. Taking the example of one representative glycan, this protocol will show how to build an IMS/IMS control sequence on a Cyclic IMS instrument, how to account for this control sequence to translate IMS arrival time into drift time (i.e., the effective separation time applied to the ions), and how to extract the relevant mobility information from the raw data. This protocol is designed to clearly explain the critical points of an IMS/IMS experiment and thus help new Cyclic IMS users perform straightforward and reproducible acquisitions.
The complete chemical characterization of biomolecules is key to understanding their underlying biological and functional properties. To this end, "omics" sciences have developed in recent years, aiming for the large-scale characterization of chemical structures at biological concentrations. In proteomics and metabolomics, MS has become a core tool to unravel the structural heterogeneity found in biological media-notably thanks to its sensitivity and ability to provide structural information through tandem MS (MS/MS). In MS/MS strategies, an ion is selected according to its mass, then fragmented, and finally, the masses of its fragments are acquired to establish a fingerprint of the molecule. MS/MS spectra can, in particular, be used to match spectral databases1,2, or tentatively reconstruct the parent structures3,4. Under the assumption that similar spectra belong to similar compounds, MS/MS data can also be used to build molecular networks (MNs) connecting related species through a similarity score5,6.
However, because of the inherent property of MS to detect the mass-to-charge ratio (m/z) of ions, the technique is blind to a number of structural features that fall within the range of (stereo)isomerism. For example, carbohydrates are made of several monosaccharide subunits, many of which are stereoisomers or even epimers (e.g., Glc vs. Gal or Glc vs. Man). These subunits are linked by glycosidic bonds, which can differ by the position of the linkage (regioisomerism) and the steric configuration of the anomeric carbon (anomerism). These characteristics make it difficult for standalone MS to distinguish between carbohydrate isomers7, and only regioisomerism can be addressed using high-energy activation methods8,9,10. Although derivatization is an option to disrupt the equivalence of stereoisomeric groups11, it requires extensive sample preparation. Another, more straightforward option is to couple MS with an analytical dimension sensitive to isomerism, such as IMS.
Because this protocol is designed for users who are already familiar with the basic concepts of IMS, and because detailed reviews are available elsewhere12,13, only a brief overview of the principles of IMS is given here. IMS is a gas-phase separation method that relies on the interaction of ions with a buffer gas and an electric field, ultimately separating ions according to their gas-phase conformations. Different principles of IMS coupled to MS can be found on commercial instruments: some operate at alternating high and low electric fields (field asymmetric IMS, FAIMS), while most operate within the low field limit—notably drift tube IMS (DTIMS, linearly decreasing electric field), traveling wave IMS (TWIMS, symmetric potential waves), and trapped IMS (TIMS, high flow of buffer gas trapping ions against electric fields)13. The low-field methods allow access to a so-called CCS, a property of the ion-gas pair that represents the surface (in Å2 or nm2) of the ion that interacts with the buffer gas during the separation. CCS is theoretically instrument-independent and is thus useful to generate data that can be reproduced between different laboratories14. Ion mobility separations can be impacted by various parameters and, notably, by fluctuations of the gas pressure and gas temperature in the mobility cell. The CCS calibration is a way to remedy this, as both the calibrant and the species of interest will be similarly affected13. However, it is mandatory to install the instrument in a temperature-controlled room and to have a reliable gas pressure control system.
An interesting evolution of IMS is IMS/IMS, which was first introduced in 2006 by Clemmer's group as an analog of MS/MS15,16. In IMS/IMS, an ion of interest is selectively isolated based on its ion mobility; it is then activated (until possible fragmentation), and a new IMS analysis of the activated ion or fragments is performed. In the first instrumental design, two IMS cells were put in series, separated by an ion funnel where the activation stood. Since then, although a number of IMS/IMS setups were proposed (for a review, see Eldrid and Thalassinos17), the first commercial mass spectrometer with IMS/IMS capability only became available in 201918. This instrument substantially improved the initial concept by combining it with another technological breakthrough: a cyclic design of the IMS cell.
The cyclic IMS cell theoretically allows increasing near-infinitely the drift path length and, thus, the resolving power of the instrument19. This was achieved by means of a particular instrument geometry, where the cyclic TWIMS cell is placed orthogonally to the main ion optical axis. A multifunction array region at the entrance of the IMS cell allows controlling the direction of the ion path: (i) sending ions sideways for IMS separation, (ii) forward for MS detection, or (iii) backward from the IMS cell to be stored in a prearray cell. From this prearray store cell, the ions can be activated and the fragments reinjected in the IMS cell for ion mobility measurement, an approach that has been successfully used to characterize stereoisomers20. Ultimately, the collected data contain ion mobility and m/z information for the precursor and its fragments.
In a recent publication that used this cyclic design for glycan analyses (Ollivier et al.21), we showed that the mobility profile of the fragments contained in such IMS/IMS data acts as a fingerprint of a biomolecule that can be used in a molecular networking strategy. The resulting network, called IM-MN, led to the organization of glycomics datasets in a structurally relevant way, whereas the network built solely from MS/MS data (MS-MN) revealed little information. To complement this publication and help Cyclic IMS users implement this workflow, this protocol provides a complete description of the protocol used to collect the data. This protocol focuses only on the generation of the IMS/IMS data that users can then use to build IM-MN networks (see21)—or for any other application of their choice. Building of IM-MN will not be considered herein, as protocols for molecular networking are already available22. The crucial points that must be followed to generate valuable and reproducible IMS/IMS acquisitions are highlighted. Taking the example of one of the oligosaccharides studied by Ollivier et al.21, the following steps are detailed: (i) sample preparation, (ii) tuning of the Cyclic IMS instrument, (iii) automated peak-picking of the data, and (iv) CCS calibration.
NOTE: An overview of the protocol is provided in Figure 1. The parameters used for the experiments described in the present protocol can be found in Supplemental Table S1 and Supplemental Table S2.
1. Preparation of the sample solution
NOTE: The protocol is described using an arabinoxylan pentasaccharide (23-α-L-arabinofuranosyl-xylotetraose or XA2XX; see the Table of Materials) as an example.
2. Tuning of the Cyclic IMS mass spectrometer
NOTE: Software-related instructions (windows, menus, and commands) are highlighted in bold.
3. IMS/IMS-MS acquisition
4. IMS/IMS-MS processing with MZmine 224
NOTE: MZmine 2 is available from the URL given in the Table of Materials. The use of MZmine 2.51 is recommended. At the time of preparation of this manuscript, the later versions cannot open RAW files from Cyclic IMS instruments because of a change in the import function.
5. TWCCSN2 of the centroided IMS/IMS spectra
NOTE: In this protocol, a logarithmic fit calibration25,26 will be used, which tends to give better results than linear calibration and is easy to implement in a spreadsheet or an in-house processing script. An in-house script (written in R) is available at the URL given in the Table of Materials.
An arabinoxylan pentasaccharide, XA2XX, was chosen as an example to illustrate this protocol. This compound is commercially available, but only as a mixture with another arabinoxylan pentasaccharide, XA3XX (pure XA3XX is also commercially available). The structures of XA2XX and XA3XX are given in Supplemental Figure S1. As the ratio of XA2XX and XA3XX in the commercial mixture is ~50:50, a solution at 20 µg/mL of the mixture was prepared to reach an XA2XX concentration of ~10 µg/mL in 50:50 MeOH/H2O + 500 µM LiCl.
First, an MS analysis of the XA2XX + XA3XX mixture was performed using high-resolution MS. As the two compounds are isomers, a single peak was observed at [M+Li]+m/z 685.24. This MS peak was selected with the quadrupole and the selection window adjusted to remove the -1 Da lithium isotope, which could be mistaken as the monoisotopic peak by processing algorithms (Figure 2).
The [M+Li]+ adducts of the pentasaccharides were then submitted to the first stage of IMS separation: after 3 passes around the cyclic IMS cell, 3 peaks were separated with arrival times of 83, 90, and 94 ms. This profile was compared to that of pure XA3XX (infused at 10 µg/mL), showing that the peaks at 83 and 90 ms corresponded to XA3XX, while the peak at 94 ms corresponded to XA2XX (Figure 4A). The peak at 94 ms was selected for IMS/IMS analysis: the ions belonging to XA3XX were ejected (Figure 4B), and the peak of interest was sent to the prearray store cell. A 3-pass separation was performed after reinjecting the ion without activation to ensure that only the XA2XX peak remained after the selection (arriving at 199 ms in Figure 4C).
Then, the ion was fragmented upon reinjection from the prestore area, and a single-pass IMS separation was performed on all the fragments. Two different activations were tried: the maximum setting of the built-in prestore activation function was first tried (Figure 5B,C); however, the precursor remained the base peak of the spectrum. This is not desired because, for reference spectra, fragments below a certain intensity threshold would typically be removed. Thus, a manually defined prearray gradient → pre-array bias → array offset voltage gradient was chosen (Figure 5D,E).
The generated IMS/IMS-MS data were deconvolved with MZmine 2.51, using the arrival time and m/z dimensions (Figure 6A), to give IMS/IMS spectra containing only the mobility information of the fragments. The peaks above 0.2% relative intensity were exported for CCS calibration (the detailed MZmine parameters are given in Supplemental Table S1). The CCS calibration was performed using the calibration solution (R2 = 0.995, mean absolute deviation of control = 1.63%, see Supplemental Table S3). This processing finally afforded a centroided, CCS-calibrated, IMS/IMS spectrum (Figure 6B).
Figure 1: Overview of the IMS/IMS data generation process. Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS. Please click here to view a larger version of this figure.
Figure 2: Isotopic pattern of an XA3XX + XA2XX arabinoxylan pentasaccharide mixture. (A) Saturated signal without DRE; (B) signal corrected using DRE with a 5% ion transmission (i.e., 95% attenuation); and (C) profile after quadrupole selection to remove the -1 Da peak corresponding to a lithium isotope. In purple: the region where artifact peaks can appear due to saturation is magnified 6 times. Abbreviations: DRE = dynamic range enhancement; MS = mass spectrometry; MSMS = tandem MS; LM Res = low-mass resolution; HM Res = high-mass resolution. Please click here to view a larger version of this figure.
Figure 3: Overview of the Cyclic IMS control window, in which the user defines the IMS/IMS sequence. The sequence displayed shows how to check the quality of the isolation in IMS/IMS, with a selection of XA2XX after 3 passes (the spectrum displayed corresponds to the setting of the selection events after the first-stage separation). The sequence consists in running a first 3-pass IMS separation over 58 ms, then ejecting the two faster isoforms from the IMS cell (segment 3), ejecting the slower isoform (ATD between 92 and 96 ms) in the prestore (segment 4), reinjecting it in the IMS cell without activation (segment 6), allowing the ions to undergo a further 3-pass (58-ms) separation (segment 7), then ejecting ions from the IMS cell, and acquiring data (segment 8). Abbreviations: IMS = ion mobility spectrometry; cIMS = cyclic IMS; IMS/IMS = tandem IMS; ADC = analog-to-digital converter; TW = traveling wave; PE = potential energy; ATD = arrival time distribution. Please click here to view a larger version of this figure.
Figure 4: Selection of XA2XX from the mixture of XA2XX and XA3XX. (A) Separation of the arabinoxylan pentasaccharides, XA3XX and XA2XX, after 3 passes (corresponding to a separation time set at 58 ms) around the Cyclic IMS cell. (B) Fraction ejected directly after the first stage of IMS separation. (C) Fraction selected for IMS/IMS on which another 3-pass separation was performed after reinjection. The XA2XX peak of interest is highlighted in gray. The ion mobility spectra are shown in data bins and annotated with their arrival time (ms). Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS. Please click here to view a larger version of this figure.
Figure 5: Principles of collision-induced dissociation using the prearray store area. (A) Schematics of the multifunction array region detailing key voltages (in red) used for the selection, the reinjection, and the activation during IMS/IMS experiments. The blue arrows show the direction of the traveling wave in the multifunction array. (B, C) IMS/IMS and MS/MS spectra obtained for XA2XX using the built-in prestore activation function (+150 V). The color bar represents the ion intensity scale (blue = low; red = high). (D, E) IMS/IMS and MS/MS spectra obtained for XA2XX with manual optimization of the voltages (prearray gradient 195 V, prearray bias 180 V, array offset -10 V). Precursor ions are indicated by asterisks on the spectra. The ion mobility spectra are shown in data bins and annotated with their arrival time (ms). Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS; TOF = time-of-flight. Please click here to view a larger version of this figure.
Figure 6: Illustration of the processing steps. Results of (A) the MZmine peak picking and (B) the CCS calibration of arabinoxylan pentasaccharide XA2XX. A shows the mass deconvolution of the IMS/IMS spectrum through a color code. B shows the final IMS/IMS spectrum after centroiding and CCS calibration. Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS; CCS = collision cross section. Please click here to view a larger version of this figure.
Figure 7: A comparison of two IMS/IMS spectra of XA2XX illustrates the reproducibility of the method. The final calibrated spectrum from this paper (top) is compared to the spectrum from the work by Ollivier et al.21 (bottom, flipped). Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS; CCS = collision cross section. Please click here to view a larger version of this figure.
Supplemental Figure S1: Structures of the XA2XX and XA3XX arabinoxylan pentasaccharides. Please click here to download this File.
Supplemental Figure S2: Evaluation of the interday repeatability using XA2XX. IMS/IMS acquisitions were repeated at Day 1 (top) and Day 95 (bottom). Abbreviations: IMS = ion mobility spectrometry; IMS/IMS = tandem IMS. Please click here to download this File.
Supplemental Table S1: Detailed MZmine parameters. Please click here to download this Table.
Supplemental Table S2: Instrument parameters changed to evaluate the reproducibility. Abbreviation: ESI = electrospray ionization. Please click here to download this Table.
Supplemental Table S3: Control of the CCS calibration using a second acquisition of calibration solution. Please click here to download this Table.
The SELECT SERIES Cyclic IMS is a powerful tool that allows selecting a defined ion population—of a given m/z and ion mobility—without the need for upstream chromatographic separation. The instrument affords the possibility of generating a bidimensional fragmentation map of this ion population, from which both MS/MS and IMS/IMS spectra can be extracted. However, the user must note several critical points that require attention during the experimental process.
First, the user should carefully check the MS isolation window for the presence of possible isobaric contaminants. Indeed, the isolation window of a quadrupole is relatively wide, and knowing ions of a slightly different m/z that may be coselected in the quadrupole will help the user properly assign the peak of interest in ion mobility.
Second, when performing the initial separation, the user must ensure that all ions undergo the same number of passes around the Cyclic ion mobility cell. This is an important and tricky aspect of ion mobility separation in a cyclic device. An erroneous evaluation of the number of passes for a given ion may lead to an improper identification and interpretation of the peaks. Controlling the number of passes of different ion populations can be tricky owing to the relatively short single-pass length (~1 m), and species with very different mobilities can quickly overlap.
In particular, a peak can split between two different passes if the array switches direction when this ion population passes through (this is relatively easy to identify: the split peak will appear sharper with a population right at the beginning of the Eject and Acquire event). To properly set the number of passes, the user should start with a short separation time (1-5 ms) that will give the 1-pass profile. Then, the user should gradually increase the separation time until the entire population has moved to higher arrival times, which will give the 2-pass profile. The 2-pass profile should look similar to the 1-pass profile but with better-resolved peaks. The time a given ion population takes to make one pass around the cyclic cell is a constant that the user can use to calculate the number of passes as a function of the separation time. For instance, if there is a 10 ms difference between the first and second pass, there will also be a 10 ms difference between the second and the third.
Third, during the IMS selection stage, the user should carefully check the quality of the isolation, as demonstrated in Figure 4. It is especially important to check the reinjected profile because if the TW height and velocity settings are too low, the ejection of the other populations might not be complete. Advanced users can correct this by adjusting the Driftcell RF radiofrequency voltage in the RF tab of the Tune page.
Fourth, the user should be careful in generating the fragmentation spectrum and, notably, in selecting the appropriate collision energy, especially if the voltages are tuned manually. Indeed, excessively lowering the Array Offset voltage can negatively impact the overall ion intensity by hindering the reinjection. In addition, the precursor and fragments might span over a wide range of mobilities. Thus, they will rapidly undergo a different number of passes if the final separation time is high, so it is important to keep a 1-ms Separate event as explained in protocol step 2.3.3. This is a major limitation since the single-pass length is relatively short, limiting the single-pass resolving power to ~100 for oligosaccharides27. In this respect, an increased path length in a single pass would be beneficial (i.e., the TWIMS-based Structures for Lossless Ion Manipulation or SLIM, with a path length of 13 m28). The SLIM setup was launched commercially very recently29.
Finally, the user should be careful in defining the final acquisition mobility range using the Pushes per bin command, particularly if working on multiply charged ions. Ion mobility is indeed a function of the charge12, and, for example, singly-charged fragments generated from a doubly-charged precursor are likely to be slower than the precursor (although they are smaller compounds).
A major limitation of using only MS and IMS separations to select the precursor (and not, for instance, an upstream step of chromatography) is that a given m/z can yield multiple peaks in IMS and that multiple peaks can come from the same compound. This is illustrated by the distributions of m/z 685.2, for both the XA2XX+XA3XX mixture and pure XA3XX, in Figure 4A. Multimodal IMS distributions of a single m/z result from different gas-phase conformations. For species analyzed as cation adducts (in positive mode), the different conformations possibly arise from differences in coordination with the counter-ion30,31,32.
For oligosaccharides, they can also arise from the separation of reducing-end anomers, although separating reducing-end anomers typically requires higher IMS resolving power than what is used here33,34,35. In the present case, the multimodal IMS distribution in Figure 4A results partly from the individual contributions of XA2XX and XA3XX. It is, however, notable that XA3XX yields two peaks, which are likely cation-coordination conformers. It was easy to identify which peak corresponded to XA2XX (i.e., the species of interest) because pure XA3XX is available commercially, and its mobility profile could be recorded separately. To work on complex mixtures such as biological media, it may be important to consider adding a chromatographic separation stage.
Two points must be noted regarding the processing workflow used to obtain mass-deconvolved IMS/IMS spectra. First, in this protocol, it is proposed to use MZmine 224 to deconvolve the IMS/IMS spectrum using the MS dimension and, notably, use the ADAP algorithm36 to split the EIMs into different peaks. Although it gives fairly good results, as illustrated in Figure 6, the ADAP algorithm was designed for chromatographic analyses and thus accounts for asymmetry factors inherent to liquid phase chromatography, such as peak tailing. Therefore, the ADAP algorithm might result in not identifying some of the features when applied to IMS peaks (e.g., shoulders). In essence, IMS data are simpler than chromatographic data: because there is no chemical interaction of the compounds with a column, IMS data acquired under appropriate conditions (i.e., without saturating the IMS cell) are expected to follow gaussian distributions37,38. Ideally, the ADAP deconvolution step would be best replaced by a gaussian fitting function, such as that used by software destined for IMS like CUISuite 239. However, as it stands, gaussian deconvolution was not directly adapted to the complete chain of treatment described in this protocol. Therefore, using the free, open-source software MZmine appeared to be a good compromise for end-users.
The second part of the processing that warrants discussion is the CCS calibration. This protocol proposes using a logarithmic fit calibration25,26 and a commercial calibrant mixture from the same provider as that of the spectrometer (see the Table of Materials). This procedure is the most straightforward to implement in the lab. Regarding the choice of the calibrant mixture, the user should consider that, as mentioned in several studies, the accuracy of the CCS calibration is improved when using calibrants of the same molecular class and charge state as the analyte26,40,41. The error introduced when calibrating with relatively similar types of compounds (e.g., carbohydrates vs. peptides) is moderate. However, it is recommended not to use very different ions such as, for example, using salt clusters as calibrants when measuring carbohydrates41. Regarding the choice of the calibration method, Richardson et al.42 recently reported a new calibration method that takes into account the physics of TWIMS to improve the accuracy of the calibration (with a provided software). However, the approach requires the evaluation of highly specific parameters through the analysis of various types of compounds—ranging from metabolites to native proteins. Because no mixture of such a variety of compounds can be found commercially, this method was not implemented in the present protocol.
Finally, to evaluate the reproducibility of the method, we evaluated the interday reproducibility by repeating the IMS/IMS-MS acquisition at day 1 and day 95 (Supplemental Figure S2). The experiment showed that IMS/IMS-MS data are highly reproducible, with no IMS peak shifting by more than 0.2 ms over this extended period. The IMS/IMS spectrum generated in this work was further compared to another spectrum of XA2XX acquired under different conditions for previous work on ion mobility-molecular networking21. Some instrumental parameters that can impact the ion structure and ion mobility profile13 were deliberately changed—the source parameters and the activation voltage gradient (a comparison of the varying instrumental conditions is given in Supplemental Table S2). Then, the two spectra were compared using the cosine similarity score—which is popular for the comparison of MS/MS spectra in metabolomics—on the GNPS platform5 (CCS tolerance for matching fragments = 0.015 nm2).
The comparison showed a cosine similarity score of 0.87 (Figure 7), which can be considered high with regard to the important instrumental variations applied. This leads to the idea that IMS/IMS spectral libraries could be used to dereplicate glycans in complex mixtures with a high level of confidence, which would not be the case with MS/MS spectra. Note that although the current approach only uses the CCS dimension of the fragmentation spectrum, the IMS/IMS-MS data also contains MS information, which is not redundant with the CCS. To optimize the dereplicative power of IMS/IMS, a bidimensional scoring system must be developed.
The authors have nothing to disclose.
S.O. is thankful to the French National Research Agency for funding his Ph.D. (grant ANR-18-CE29-0006).
33-α-L- plus 23-α-L-Arabinofuranosyl-xylotetraose (XA3XX/XA2XX) mixture | Megazyme Ltd., Wicklow, Ireland | O-XAXXMIX | XA2XX + XA3XX mixture |
33-α-L-Arabinofuranosyl-xylotetraose (XA3XX) | Megazyme Ltd., Wicklow, Ireland | O-XA3XX | Pure XA3XX standard |
Eppendorf Safe-Lock Tubes, 1.5 mL, Eppendorf Quality, colorless, 1,000 tubes | Eppendorf, Hamburg, Germany | 0030120086 | Used to prepare the carbohydrate stock solution and dilution |
FALCON 50 mL Polypropylene Conical Tube 30 x 115 mm | Corning Science México S.A. de C.V., Reynosa, Tamaulipas, Mexico | 352070 | Used to prepare the aqueous stock solution of 100 mM LiCl |
Lithium Chloride (ACS reagent, ≥99 %) | Sigma-Aldrich Inc., Saint Quentin Fallavier, France | 310468 | Used to dope the sample with lithium |
Major Mix IMS/Tof Calibration Kit | Waters Corp., Wilmslow, UK | 186008113 | Calibration solution for MS and IMS |
MassLynx 4.2 SCN1016 Release 6 (Waters Embedded Analyser Platform for Cyclic IMS 2.9.1 Release 9) | Waters Corp., Wilmslow, UK | 721022377 | Cyclic IMS vendor software for instrument control and data processing |
Methanol for HPLC PLUS Gradient grade | Carlo-Erba Reagents, Val de Reuil, France | 412383 | High-purity solvent |
MS Leucine Enkephaline Kit | Waters Corp., Wilmslow, UK | 700002456 | Reference compound used for tuning of the mass spectrometer |
SCHOTT DURAN 100 mL borosilicate glass bottle | VWR INTERNATIONAL, Radnor, Pennsylvania, US | 218012458 | Used to prepare the solution of 500 µM LiCl in 50:50 MeOH/Water |
SELECT SERIES Cyclic IMS | Waters Corp., Wilmslow, UK | 186009432 | Ion mobility-mass spectrometer equipped with a cylic IMS cell |
Website: http://mzmine.github.io/ | MZmine Development Team | – | Link to download the MZmine software |
Website: https://github.com/siollivier/IM-MN | INRAE, UR BIA, BIBS Facility, Nantes, France | – | Link to an in-house R script containing a CCS calibration function |